Trade Show

Suzhou Dialogue 2026: Meet Datwyler at the CNPPA Forum

Datwyler's Expert Perspective on China Pharmacopoeia, USP 382, and EU Annex 1 Compliance

  • Participating in this high-level industry dialogue hosted by the China National Pharmaceutical Packaging Association
  • Topics: container closure integrity, elastomer innovation, and quality systems for evolving Chinese regulatory requirements
  • Engaging leading pharmaceutical manufacturers and regulators shaping China's packaging standards
Date September 2, 2026 – September 3, 2026
Location Suzhou, China
Details Booth #16
Schedule a Meeting
Event Overview

Datwyler at the Suzhou Dialogue: Elastomer Expertise for China's High-Value Injectable Market

The Suzhou Dialogue, convened by the China National Pharmaceutical Packaging Association, is one of China's most substantive forums for packaging regulatory dialogue. This year, Datwyler co-hosts the sub-forum "Sealing · Testing · Drug Delivery: Building an End-to-End Solution for High-Barrier Combination Drug-Device Products" alongside ZwickRoell and HealthyTree Medical Device on the afternoon of September 2. David Qiu, Key Account Manager at Datwyler, takes the stage to present "From Trends to Practice: The Critical Role and Technical Challenges of Elastomer Components in High-Value Injectable Drug Products," with a focus on NeoFlex™ platform functionality and the latest regulatory updates.

Want to connect?

Our team is bringing the technical documentation and global regulatory track record to help manufacturers navigate multi-market compliance, covering:

  • China Pharmacopoeia standards for elastomeric components and USP 382 expectations for plastic and elastomeric packaging
  • EU Annex 1 sterile manufacturing requirements

All supporting Chinese pharmaceutical manufacturers in navigating multi-market compliance with confidence.

Featured Presentations

Presentation Details

From Trends to Practice: The Critical Role and Technical Challenges of Elastomer Components in High-Value Injectable Drug Products

Date & Time September 2, 2026 • 1:00 PM

David Qiu, Key Account Manager at Datwyler, presents "From Trends to Practice: The Critical Role and Technical Challenges of Elastomer Components in High-Value Injectable Drug Products" on the afternoon of September 2.

  • Participating in this high-level industry dialogue hosted by the China National Pharmaceutical Packaging Association
  • Topics: NeoFlex™ platform functionality and the latest regulatory updates shaping elastomer component selection for combination drug-device products
  • Engaging leading pharmaceutical manufacturers and regulators shaping China's packaging standards
View David Qiu
Speaker Spotlight

Meet the Speakers

David Qiu

David Qiu

Key Account Manager | Datwyler
David Qiu graduated from China Pharmaceutical University with a degree in Pharmaceutical Formulation and Pharmaceutical Engineering. Prior to joining Datwyler, he held positions in the R&D departments of companies such as Fresenius. He has nearly 20 years of experience in the R&D of pharmaceuticals and medical devices, with extensive expertise in the analytical testing of packaging materials, formulations, and raw materials, as well as in the study of elemental impurities and extractables and leachables.
Solutions Spotlight

What We're Showcasing at Suzhou Dialogue by CNPPA

Explore the solutions and technologies most relevant to this event.

Container Closure Systems Engineered for Injectable Precision
Featured Solution

Container Closure Systems Engineered for Injectable Precision

From stoppers and plungers to aluminum seals and tip caps, Datwyler's comprehensive container closure portfolio will be on display — offering pharmaceutical manufacturers a full suite of solutions for injectable, biologic, and combination drug products.
Advanced Elastomer Science for Next-Generation Drug Containment
Featured Solution

Advanced Elastomer Science for Next-Generation Drug Containment

Datwyler showcases how advances in elastomer material science — including monomeric PFAS-free coatings, silicone-free formats, and ultra-clean manufacturing — are driving the next generation of drug containment solutions, supporting pharmaceutical manufacturers in meeting evolving regulatory requirements and formulation compatibility demands. 
Pharmaceutical Packaging Solutions for China's Growing Market
Featured Solution

Pharmaceutical Packaging Solutions for China's Growing Market

Datwyler presents its comprehensive portfolio of container closure systems, elastomers, and drug delivery components tailored for China's pharmaceutical market — addressing the quality, regulatory, and scalability demands of a rapidly expanding domestic and export-focused industry.
Additional Information

Continue Exploring

Access additional materials and information related to this event and Datwyler’s solutions.

Resource Critical Updates to Regulatory Requirements for Injectable Packaging
→
Resource Out With the Old: Advancing the Chemical Cleanliness of Rubber Components
→
Resource Sealing Solutions for Healthcare
→
Helpful Information

Frequently Asked Questions

What is the Suzhou Dialogue?
The Suzhou Dialogue is a high-level industry dialogue hosted by the China National Pharmaceutical Packaging Association on China's evolving packaging regulatory standards.
When is the Suzhou Dialogue 2026?
The event takes place September 2–3, 2026, in Suzhou, China.
Is Datwyler presenting at the Suzhou Dialogue?
Yes. Datwyler co-hosts the sub-forum "Sealing · Testing · Drug Delivery: Building an End-to-End Solution for High-Barrier Combination Drug-Device Products" with ZwickRoell and HealthyTree Medical Device on the afternoon of September 2. David Qiu, Key Account Manager at Datwyler, presents "From Trends to Practice: The Critical Role and Technical Challenges of Elastomer Components in High-Value Injectable Drug Products," covering NeoFlex™ functionality and the latest regulatory updates.
EVENT UPDATES

Stay informed on upcoming Datwyler events

Subscribe to receive updates on conferences, presentations, and opportunities to connect with our team.